Extracellular recording techniques have been used in the guinea pig hippocampal slice preparation to investigate the electrophysiological actions of the organophosphate (OP) anticholinesterase soman. When applied at a concentration of 100 nM, soman induced epileptiform activity in the CA1 region in approximately 75% of slices. This effect was mimicked by the anticholinesterases paraoxon (1 and 3 M), physostigmine (30 M), and neostigmine (30 M), thus providing indirect evidence that the epileptiform response was mediated by elevated acetylcholine levels. Soman-induced bursting was inhibited by the muscarinic receptor antagonists atropine (concentrations tested, 0
benzodiazepine anticonvulsants diazepam (3-30 M) and midazolam (3-30 M), but it was not inhibited by the nicotinic antagonists mecamylamine (30 M) and methyllycaconitine (300 nM). In contrast to soman-induced epileptiform activity, bursting induced by the K ϩ channel blocker 4-aminopyridine (30 M), the adenosine A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (30 nM) or perfusion with low Mg 2ϩ buffer was insensitive to atropine (10 M). The ability of muscarinic antagonists and benzodiazepines to inhibit soman-induced epileptiform activity is in accordance with the in vivo pharmacology of soman-induced seizures and suggests that the guinea pig hippocampal slice preparation may provide a useful tool for the evaluation of novel anticonvulsant therapies for the treatment of seizures related to OP poisoning.
OP insecticides (e.g., paraoxon) and nerve agents (e.g., soman and sarin) exert their toxicity by irreversibly inhibiting AChE, leading to ACh accumulation and overstimulation of cholinergic pathways (Taylor, 1996) . The symptoms and signs of OP intoxication are predominantly due to muscarinic receptor overstimulation and include miosis, bronchoconstriction, bradyarrhythmias, seizures, and respiratory failure (McDonough and Shih, 1997; Brown and Brix, 1998; Lallement et al., 1998) .
Treatment for mild OP intoxication consists of a muscarinic receptor antagonist (atropine) and an oxime reactivator of OP-inhibited enzyme (e.g., pralidoxime). In moderate-tosevere OP intoxication, a benzodiazepine (e.g., diazepam) may be added in an effort to control seizures and convulsions (Lallement et al., 1998; McDonough et al., 2000) . However, benzodiazepine treatment, although efficacious in the majority of circumstances, has scope for improvement: OP-induced seizures can sometimes reoccur despite treatment, and even when seizures are abolished, neuronal damage can still arise (Hayward et al., 1990; Baze, 1993; . The undesirable side effects of the benzodiazepine class of drugs (namely, sedation and respiratory depression) provide further impetus to identify more effective anticonvulsants for OP intoxication.
In animal experiments, the resistance of OP-induced seizures to conventional antiepileptic drugs such as phenytoin and carbamazepine therapies is well established . However, muscarinic receptor antagonists are highly effective in terminating soman-induced seizures when administered early on (i.e., 5 min after seizure onset) but become less efficacious when treatment is delayed for more than 10 min and can become ineffective when the delay is greater than 40 min . This progressive resistance to antimuscarinic therapy is thought to reflect a time-dependent transition from cholinergic to noncholinergic seizure mechanisms (McDonough and Shih, 1997; Lallement et al., 1998; . These mechanisms include the recruitment of glutamatergic pathways as suggested by the observation that addition of NMDA antagonists (e.g., gacyclidine) to standard treatment regimes markedly improves the control and outcome of seizures (Lallement et al., 1999; Raveh et al., 1999) . A similar profile of increased resistance to medical intervention due to recruitment of NMDA pathways has been proposed for status epilepticus (Rice and DeLorenzo, 1999) .
Whereas the ability of AChE inhibitors and cholinergic agonists (e.g., pilocarpine; Turski et al., 1989) to induce seizures in vivo is well known, the precise areas of the brain involved in the initiation and maintenance of OP-induced seizures are uncertain. However, the hippocampus is an area of particular interest because it is known to be important in the initiation and maintenance of epileptic seizures. Moreover, this structure has a large cholinergic innervation (Lewis et al., 1967) and is damaged after OP-induced seizures (Hayward et al., 1990; Baze, 1993) .
The in vitro hippocampal slice preparation is widely used to investigate seizure activity and evaluate antiepileptic/anticonvulsant drugs (Oliver et al., 1977) due to its ability to exhibit epileptiform activity. A variety of manipulations can induce this state, including application of 4-aminopyridine (4-AP) (Perreault and Avoli, 1991) , 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (Alzheimer et al., 1989) , and alteration of external Mg 2ϩ (Psarropoulou and Haas, 1989) . Of particular relevance to the current study is the report by Endres et al. (1989) , who observed paraoxon-induced epileptiform activity in the CA1 region of guinea pig hippocampal slices in which the CA3 region had been removed. Epileptiform activity has also been reported in the rat hippocampal slice after application of anticholinesterases, although this has not been a universal finding (Cole and Nicoll, 1984; Lebeda and Rutecki, 1985; Williamson and Sarvey, 1985) . Although Lebeda and Rutecki consistently saw the induction of epileptiform activity after application of the anticholinesterases diisopropylphosphorofluoridate (DFP) or soman, Cole and Nicoll (1984) observed the induction of epileptiform activity in only 20 to 30% of slices after application of physostigmine, whereas Williamson and Sarvey (1985) failed to see any epileptiform activity after application of either DFP or physostigmine (although a secondary population spike was induced).
The aim of the present work was the development and characterization of an in vitro model of OP-induced seizure activity in the hope of developing a useful tool for evaluating new therapies for OP poisoning. We have investigated the ability of soman to induce epileptiform activity in the guinea pig hippocampal slice. Several other OP and carbamate anticholinesterases were also tested for their ability to induce epileptiform activity. The effects of several muscarinic and nicotinic antagonists and two benzodiazepines on the epileptiform activity were also evaluated. Finally, the effect of atropine on alternative forms of epileptiform activity was assessed. A preliminary report of this work has been published in Harrison et al. (2000) .
Materials and Methods
Guinea Pig Hippocampal Slices. Male Dunkin Hartley guinea pigs (250 -500 g) were anesthetized with halothane and killed by decapitation. The brain was then removed and the left and right hippocampi removed. The hippocampus was then cut into temporal and septal sections. The temporal section was mounted on a tissue block, and five to seven transverse slices (500 m in thickness) were prepared using a Vibratome (Intracel, Royston, UK). The slices were stored at room temperature in an ACSF of the following composition: 118 mM NaCl, 3 mM KCl, 25 mM NaHCO 3 , 1.2 mM NaH 2 PO 4 , 1 mM MgCl 2 , 1.5 mM CaCl 2 , and 10 mM D-glucose (gassed with 95% O 2 , 5% CO 2 ). Slices were left to recover for at least 1 h before transfer to a recording chamber (volume Ϸ1 ml) where they were submerged and continuously superfused (at 10 -15 ml min Ϫ1 ) with gassed ACSF at 31°C.
Electrophysiological Recordings and Application of Compounds. After a further 30-min equilibration, an extracellular recording electrode (filled with 2 M NaCl; 1-5 M⍀ resistance) was placed in CA1 stratum pyramidale to monitor neuronal activity. The Schaffer collateral/commissural pathway was then stimulated every 30 s via a bipolar stimulating electrode (stimulation pulse width Ϸ150 s, amplitude Ϸ250 A, MCE 100; Harvard Apparatus Inc., Holliston, MA), and the recording electrode lowered into CA1 changed until the population spike amplitude was maximal. Stimulation was then terminated. Baseline activity was monitored for at least 30 min before application of anticholinesterase, DPCPX, 4-AP, or low Mg 2ϩ ACSF; any slices showing spontaneous epileptiform activity during this period were discarded. For the experiments with low Mg 2ϩ ACSF, the slices were perfused with an ACSF of the same composition but with MgCl 2 omitted. Anticholinesterases were applied for up to 60 min; if epileptiform activity had not occurred by this time, the slice was classified as "unresponsive," but only after slice viability had been confirmed by the appearance of epileptiform activity after exposure to 4-AP (30 M). In slices in which epileptiform activity occurred, the activity was allowed to continue for 15 min before addition of the test compound. All compounds were applied by addition of appropriate volumes of concentrated stock solution directly into the perfusion reservoir (exchange and equilibration of added compounds with the recording chamber occurred within 3 min). In a series of separate experiments, neither 0.3% (v/v) dimethyl sulfoxide nor 0.1% (v/v) ethanol (the maximum vehicle concentrations used) had any effect on epileptiform activity (data not shown).
Data Analysis. Data were captured via a CED 1401 ADC interface controlled by Spike 2 software (Cambridge Electronic Design, (Cambridge, UK). The analog signal was digitized at 2 kHz. At the end of each experiment, the digitized trace was manually analyzed for burst characteristics (amplitude, duration, and rate) using onscreen cursors. A burst was defined as a deflection from baseline noise lasting Ͼ10 ms, with a magnitude of Ͼ0.1 mV above baseline and separated from neighboring "bursts" by a quiescent period of Ͼ2 s. To determine the effect of the various treatments on epileptiform activity, the average burst rate in the 10-min epoch immediately before treatment application was compared with the burst rate 30 to 40 min after treatment application (throughout this article, bursting and epileptiform activity are used interchangeably).
Unless otherwise specified, summarized data are presented as mean Ϯ S.E.M., with significance determined using one-way analysis of variance with Dunnett's post hoc test.
Drugs. All chemicals were obtained from Sigma Chemical (Poole, Dorset, UK) or Tocris Cookson Ltd. (Langford, UK) with the following exceptions: soman (pinacolyl methylphosphonofluoridate), purity Ͼ95%, approximately 5 mg/ml solution in isopropyl alcohol, was synthesized by the Chemistry Department, Dstl. Porton Down; biperiden lactate (Akineton; ␣-bicyclo[2. 
Results
Effect of Soman on Neuronal Activity. Administration of soman (100 nM; a concentration that should rapidly abolish acetylcholinesterase activity; Santos et al., 2003) resulted in epileptiform activity that could be recorded from the CA1 stratum pyramidale in 117/154 slices (Fig. 1) . The characteristics of epileptiform activity are summarized in Table 1 . Within an individual slice, the burst duration did not vary greatly. Once initiated, bursting continued for up to 4.5 h (the longest time recorded) and once induced the activity was unaffected by washout of soman. Application of the vehicle for soman [0.0004% (v/v) isopropyl alcohol] did not induce bursting in four slices (data not shown).
Effect of Atropine on Soman-Induced Bursting. Previous in vivo experiments have shown that soman-induced epileptiform activity can be reversed by the muscarinic receptor antagonist atropine. If the activity induced here is from inhibition of AChE (with resulting overstimulation of cholinergic pathways), it too should be sensitive to blockade of these receptors. To test this hypothesis, we investigated the effect of atropine on soman-induced activity. When applied 15 min after the development of soman-induced bursting, atropine (0.1-10 M) inhibited bursting (Fig. 2) . A significant reduction (P Ͻ 0.05) was seen at concentrations Ͼ100 nM. However, even at the highest concentration tested (10 M), bursting was never abolished, the burst rate being 23 Ϯ 11% of pretreatment (n ϭ 5).
Effect of Other Anticholinesterase Agents on Hippocampal Electrophysiology. To provide evidence that the bursting activity was due to inhibition of AChE, the effect of three other anticholinesterases was investigated. Paraoxon, applied at 1 M (four slices) and 3 M (three slices), neostigmine (30 M; four slices), and physostigmine (30 M; four slices) also induced epileptiform activity, which was sensitive to the muscarinic antagonist atropine (Fig. 3) . We could not quantify any difference in the reversal produced by atropine between anticholinesterases.
Effect of Muscarinic Antagonists on Soman-Induced Bursting. Several subtype-selective muscarinic receptor antagonists also affected soman-induced bursting. The compounds chosen were the selective M 1 antagonist telenzepine, the selective M 2 antagonist AF-DX 116, and the M 1 -preferring anti-Parkinson drug biperiden. Both telenzepine and biperiden reduced the rate of bursting in a concentrationrelated manner (Fig. 4) . A significant effect (P Ͻ 0.05) was seen for telenzepine at concentrations of Ն100 nM and for biperiden at 10 M. AF-DX 116 was less potent, only producing a significant reduction (P Ͻ 0.05) in bursting at 300 M. Time-Dependent Effect of Atropine. A characteristic of nerve agent-induced seizures in vivo is that they become increasingly resistant to antimuscarinic intervention as the seizure continues. For this reason, a series of experiments was undertaken to compare the effects of atropine (300 nM) when added 15 or 75 min after the onset of epileptiform activity. The inhibition produced was not significantly different between the two time points (P Ͼ 0.05; unpaired, twotailed t test). When added after 15 min of activity, the burst rate was 46.0 Ϯ 19% of pretreatment, whereas when added after 75 min of activity the rate was 49 Ϯ 15% of pretreatment (n ϭ 5 slices at each time point).
Effect of Nicotinic Antagonists on Soman-Induced Bursting. To test whether the epileptiform activity might also involve nicotinic receptor activation, two selective antagonists, mecamylamine and methyllycaconitine (␣7-selective), were tested. Neither 30 M mecamylamine (n ϭ 4) nor 300 nM methyllycaconitine (n ϭ 4) had any significant effect compared with control (P Ͼ 0.05; unpaired, two-tailed t test): burst rates 30 to 40 min after addition of antagonist were 180 Ϯ 24% (mecamylamine), 111 Ϯ 13% (methyllycaconitine) versus 124 Ϯ 11% in vehicle-treated slices (Fig. 5) .
Effect of Benzodiazepines on Soman-Induced Bursting. One of the most commonly used anticonvulsants in the treatment of OP poisoning is diazepam, which has previously been shown to terminate soman-induced epileptiform activity in vivo. Therefore, the effects of diazepam and another benzodiazepine anticonvulsant, midazolam, were investigated. Both anticonvulsants inhibited soman-induced bursting in a concentration-dependent manner (Fig. 6) , with a significant reduction being seen at concentrations Ն10 M for both benzodiazepines (P Ͻ 0.05).
Effect of Atropine on Nonanticholinesterase-Induced Epileptiform Activity. To investigate whether inhibition of bursting by atropine was restricted to anticholinesterase-induced epileptiform activity, the effect of atropine on epileptiform activity induced by other means was studied. Application of 30 M 4-AP (a blocker of K ϩ channels), 30 nM DPCPX (an adenosine A 1 antagonist), or perfusion with low Mg 2ϩ ACSF all induced epileptiform activity. Table 1 summarizes the characteristics of the epileptiform activity induced by the different treatments with an example of each shown in Fig. 7 . 
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The burst rate (as a percentage of pretreatment) after 10 M atropine for 4-AP-induced, DPCPX, and low Mg 2ϩ ACSF treatment was 112 Ϯ 8% (n ϭ 5), 131 Ϯ 13% (n ϭ 5), and 202 Ϯ 69% (n ϭ 6), respectively. In contrast, the burst rate after 10 M atropine for soman-induced bursting was 23 Ϯ 11%.
Discussion
The present study, which confirms and extends previous work from this laboratory (Wood and Tattersall, 2001 ), demonstrates that the irreversible anticholinesterase, soman, induces epileptiform activity in the guinea pig hippocampus in vitro. This action was mimicked by the OP anticholinesterase paraoxon, by the carbamate anticholinesterases physostigmine and neostigmine, and was inhibited by muscarinic but not nicotinic antagonists. These findings provide evidence that epileptiform activity induced by anticholinesterases in the guinea pig hippocampal slice is mediated by muscarinic receptor stimulation contingent upon inhibition of ACh hydrolysis and subsequent elevation of ACh concentration.
Although the site of initiation of anticholinesterase-induced epileptiform activity was not explored, work by others suggests that the CA1 region in isolation is capable of generating OP-induced epileptiform activity. Endres et al. (1989) , using guinea pig hippocampal slices in which the CA2/CA3 region had been removed, found that paraoxon elicited muscarinic receptor-mediated bursting in the CA1 region in Ϸ 70% of slices. The decision to leave the CA2/CA3 region intact in the slices used here was predicated on the fact that this region would contribute in vivo to any anticholinesterase response.
The proportion of OP-responsive slices in this study (Ϸ 75%) is similar to that reported by Endres et al. (1989) . Why some slices did not respond to OP application is unclear, but it is conceivable that the orientation of the hippocampus during preparation and the precise locale of the slice within the hippocampus (septal versus temporal) may determine the extent to which cholinergic afferents are preserved and consequently the inherent excitability of individual slices (Lewis et al., 1967; Lee et al., 1990) .
The ability of anticholinesterases to induce epileptiform activity or increase excitability has also been reported in rat hippocampal slices. Lebeda and Rutecki (1985) reported that the OP anticholinesterases DFP and soman induced atropine-sensitive epileptiform discharges in the CA3 region of rat hippocampus in vitro. Although Williamson and Sarvey (1985) failed to detect epileptiform activity in CA1 after application of DFP or neostigmine, they did find that anticholinesterases induced a secondary population spike.
In common with atropine, other muscarinic receptor antago- nists reduced the frequency of soman-induced epileptiform bursting. The rank order of potency of these antagonists (telenzepine Ͼ biperiden Ͼ Ͼ AF-DX 116) tentatively suggests that the effects of soman may be mediated by the action of endogenous ACh on M 1 muscarinic receptors. Multiple muscarinic subtypes are present within the hippocampus, with M 1 /M 3 subtypes thought to be located predominantly postsynaptically and M 2 /M 4 subtypes modulating transmitter release presynaptically (Boddeke, 1991; Levey et al., 1991; McKinney et al., 1993) . ACh exerts muscarinic receptor-mediated excitatory actions (Cole and Nicoll, 1984; Madison et al., 1987) . Previous reports support the idea that antagonists at the M 1 receptor might be more efficacious in the treatment of OP poisoning in vivo. Thus, pretreatment with the M 1 -selective antagonist pirenzepine prevented the initiation of seizures induced by carbachol in 91% of rats compared with only 9% for the M 2 -selective antagonist methoctramine (Cruickshank et al., 1994) .
In addition to a postsynaptic excitatory action via muscarinic receptors, soman-induced epileptiform bursting could also be mediated by suppression of GABAergic inhibition. Two opposing effects of cholinoceptor stimulation on GABA A receptor-mediated inhibition have been reported in the guinea pig hippocampus (Behrends and ten Bruggencate, 1993) : 1) a decrease in the frequency of miniature IPSCs, and 2) a potentiation of spontaneous IPSCs. Santos et al. (2003) , recording from rat CA1 neurones, obtained direct evidence for a muscarinic receptor-mediated effect of soman on inhibitory responses subserved by GABA A receptors: soman decreased the amplitude and frequency of spontaneous IPSCs and reduced the amplitude of evoked IPSCs. However, no effect on miniature IPSCs was observed (Santos et al., 2003) .
Of note in the present study was the failure to obtain a complete inhibition of soman-induced epileptiform discharges with muscarinic receptor antagonists, suggesting that a component of the epileptiform activity is mediated by a nonmuscarinic mechanism. One potential candidate mechanism is nicotinic receptor stimulation. Although there are no reports in guinea pig, it is well established that nicotine can induce seizures in mice (Damaj et al., 1999) and rats (Newman et al., 2001) . Nicotinic receptor agonists have also been reported to enhance ongoing epileptiform activity induced by 4-aminopyridine, bicuculline, and low Mg 2ϩ perfusion in rat hippocampal slices (Roshan-Milani et al., 2003) . However, the failure of mecamylamine and methyllycaconitine to inhibit bursting in our study argues against the involvement of nicotinic receptors in sustaining soman-induced activity.
One hypothesis for the failure to completely inhibit somaninduced bursting with muscarinic antagonists is that epileptiform activity, once initiated by overstimulation of muscarinic receptors, is maintained after recruitment of noncholinergic pathways. Evidence for the secondary involvement of glutamatergic mechanisms in primates has been presented by Lallement et al. (1999) , who reported that treatment with atropine, oxime, and diazepam after soman-intoxication failed to control seizure activity, but if gacyclidine (a noncompetitive NMDA antagonist) was also included, normal EEG activity was restored. McDonough et al. (2000) , comparing the effects of a series of antimuscarinic drugs on soman-induced seizure activity in guinea pigs, reported that the antiseizure potency of the antagonists decreased by Ϸ10-fold when treatment was delayed from 5 to 40 min. In an attempt to determine whether our slices showed a time-dependent change in sensitivity to atropine, a series of experiments were undertaken to compare the effect of atropine after 15 or 75 min of soman-induced epileptiform activity. However, we found no significant difference at these two time points. In this regard, then, our in vitro model does not mimic the pharmacology of soman in vivo. However, a confounding feature of the present slice model is the requirement to wait for the induction of a moderately stable baseline bursting rate upon which the effects of any intervention may be quantified. It is therefore conceivable that any adaptive change in the sensitivity of the bursting to atropine may have already occurred. Two clinically used benzodiazepine anticonvulsants, diazepam and midazolam, were examined for their effect on soman-induced epileptiform activity. These drugs can terminate soman-induced seizures in vivo (Hayward et al., 1990; McDonough et al., 2000) . Both diazepam and midazolam inhibited soman-induced epileptiform activity in the slice at concentrations Ն10 M. These concentrations are consistent with plasma concentrations reported for diazepam to terminate soman-induced seizures in guinea pigs (approximately 3-4 M; Capacio et al., 2001) . However, comparisons between our in vitro data and in vivo studies of soman-induced seizures are complicated by the need in vivo to administer adjunctive therapy to keep the animal alive; this therapy, in itself, may have anticonvulsant actions. The concentrations of diazepam and midazolam used in our experiments are also comparable with those in other in vitro slice models of epileptiform activity. When epileptiform activity was induced by penicillin in guinea pig hippocampal slices, diazepam (Ϸ10 M) was required to consistently block bursting (Schneiderman and Evans, 1986) , whereas an IC 50 of Ϸ12 M was determined for midazolam to inhibit low Ca 2ϩ -induced bursting in the guinea pig hippocampal slice (Ashton et al., 1988) . Overall, the data obtained with the benzodiazepines are in accord with the known in vivo pharmacology of OP-induced seizures and are comparable with other in vitro models of epileptiform activity.
The pharmacology of the epileptiform activity induced by soman and other anticholinesterases in the present study was clearly distinct from other forms. This difference is clearly demonstrated by the fact that atropine reduced bursting only in anticholinesterase-treated slices. This finding is perhaps not surprising given the varied mechanisms by which these epileptogenic agents act (4-AP blocks K ϩ channels, DPCPX prevents endogenous activation of inhibitory adenosine A 1 receptors, and low Mg 2ϩ enhances NMDA receptor/ion channel function and increases the probability of transmitter release).
To be considered as a useful model in which to evaluate the ability of anticonvulsants to switch off OP-induced epileptiform activity, the in vitro hippocampal slice preparation must relate to the in vivo situation. One characteristic of OP poisoning is the development of seizures (Ohbu et al., 1997; . Here, we have shown that application of the OP anticholinesterase soman, as well as other structurally diverse anticholinesterases, can induce epileptiform activity in the guinea pig hippocampal slice. The seizures induced by OPs in vivo can be treated with antimuscarinics. Here, we have shown that application of antimuscarinic compounds inhibit soman-induced epileptiform activity. Clinically, seizures associated with OP poisoning are sensitive to treatment with benzodiazepine anticonvulsants (Ohbu et al., 1997) . Again, the epileptiform activity induced here was inhibited by both diazepam and midazolam. Consequently, the guinea pig hippocampal slice may well prove a useful tool for the study of OP-induced seizures.
The next stage in the validation of the model will be to compare the efficacy of a wider range of anticonvulsants against OP-induced epileptiform activity in guinea pig hippocampus in vitro with efficacy against OP-induced seizures in guinea pig in vivo.
